adverse-events

Documents about adverse-events

• Emergency Department Crowding in Relation to In-hospital Adverse Medical Events#877131ClinicalTrials.gov
• Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study#853260ClinicalTrials.gov
• Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors#875905ClinicalTrials.gov
• Patient Profiling and Provider Feedback to Reduce Adverse Drug Events#831443ClinicalTrials.gov
• Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge#366582ClinicalTrials.gov
• Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)#855740ClinicalTrials.gov
• Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)#373600ClinicalTrials.gov
• Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting#136361ClinicalTrials.gov
• Cross Checking to Reduce Adverse Events in the Emergency Department#969770ClinicalTrials.gov
• Complications and Adverse Effects in Continuous Peripheral Regional Anesthesia#979519ClinicalTrials.gov
• The Development of a Six Sigma–Based Ulcus Decubitus Prevention Model to Respond to Adverse Events#1005062Jurnal Ners
• Risk of adverse events in elotuzumab-treated patients with multiple myeloma: a systematic review and meta-analysis#4563Europe PMC
• EU Secondary Data Post-Authorisation Safety Study of AZD1222#851457ClinicalTrials.gov
• Chemokeyp: A Feasibility Study for Realtime Safety Data-Capture for Potential Serious Adverse Drug Events#826322ClinicalTrials.gov
• Anticoagulation for Venous Thromboembolism: Impact on the Risk of Major Adverse Cardiovascular Events#1000756HAL (France)
• OAE: The Ontology of Adverse Events#739707PhilArchive
• Inherited IFNAR1 structural deficiency in severe adverse events following yellow fever vaccination#262275HAL (France)
• Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy#417538ClinicalTrials.gov
• A high burden of adverse life events and poor coping mechanisms experienced by urbandwelling black South Africans#306081SUNScholar
• Timing of Coronary Angiography, Cardiac Surgery, and Adverse Renal and Cardiac Events (MARCE)#841247ClinicalTrials.gov
• Preventing Medication Error Based on Knowledge Management Against Adverse Event#1004764Jurnal Ners
• Perioperative Respiratory Adverse events_sugammadex#902614ClinicalTrials.gov
• Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years#837889ClinicalTrials.gov
• Supplementary file 1_Adverse events associated with targeted therapy and immunotherapy for ovarian cancer: a FAERS pharmacovigilance study.docx#300638Figshare
• 21 U.S.C. § 364a — Adverse events#577279US Code (LII)
• Replication data for: Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment (Cameroon)#641144DataSuds Dataverse OAI Archive
• MC1R Mutations Associated With Red Hair and Perioperative Anesthesia Complications#861856ClinicalTrials.gov
• Emerging Perspectives on Adverse Childhood Experiences and Brain Cancer Immunotherapy#314713Europe PMC
• Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE)#238184ClinicalTrials.gov
• Drug-Related Problems : Focus on Age and Diabetes#283174ClinicalTrials.gov
• An evolutionary approach to the representation of adverse events#709776PhilArchive
• Effectiveness of a Proficiency-based Progression Communication Training Programme#858701ClinicalTrials.gov
• Echocardiography as Risk-Assessment for Major Adverse Cardiac Events in Major Vascular Surgery Patients#886868ClinicalTrials.gov
• Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.#841709ClinicalTrials.gov
• Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients#184869ClinicalTrials.gov
• Preventing Adverse Drug Events With PatientSite#878607ClinicalTrials.gov
• Association Between Drug-related Cutaneous Adverse Events and Progression Free Survival in Patients Treated with Enfortumab Vedotin#905202ClinicalTrials.gov
• Monitoring Adverse Events Through Bayesian Nonparametric Clustering Across Studies#650645arXiv (OAI Expanded)
• Monitoring Adverse Events Through Bayesian Nonparametric Clustering Across Studies#652098arXiv (All)
• Evaluation of Screen Time and Digital Media on ADHD#854810ClinicalTrials.gov
• Adverse Events With Magnesium Sulfate#995311ClinicalTrials.gov
• Checkpoint inhibitor effectiveness after corticosteroids and second-line immunosuppressants for immune-related adverse events in non-small-cell lung cancer#374506HAL (France)
• Domperidone and the Risk of Serious Adverse Events#852134ClinicalTrials.gov
• Adverse events of romidepsin versus tucidinostat for peripheral T-cell lymphoma: a pharmacovigilance study using the Japanese adverse drug event report database#223135OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults#885594ClinicalTrials.gov
• Blood Transfusions in Thalassemia Patients, Complications and Adverse Effects#890710ClinicalTrials.gov
• Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study#871600ClinicalTrials.gov
• COST2CARE: Improving Visibility of Nursing Sensitive Adverse Events in Ireland#623795DORAS
• Video Monitoring FOR Early Signaling of Adverse EvEnts, Technical Validation#864165ClinicalTrials.gov
• 50 Years of Immunization—Steps Forward#486674Directory of Open Access Books